Out-of-Pocket Costs Could Deter Patients from Genetic Risk Tests
June 06, 2012
Out-of-Pocket Costs Could Deter Patients from Genetic Risk Tests
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- French Insurer to Cover Epigenomics' Colorectal Cancer Test
July 5, 2012 / GenomeWeb Daily News - Survey of Canadian Cancer Patients Reveals Their Willingness to Pay for PGx Tests
June 6, 2012 / Pharmacogenomics Reporter - UK Insurers Extend Genetic Testing Moratorium
April 8, 2011 / GenomeWeb Daily News - Lack of FDA Guidance on KRAS Testing Creates Confusion; Pharmas See Lower Sales
February 4, 2009 / Pharmacogenomics Reporter - Researchers ID Colorectal Cancer Subtypes through Expression Profiling; Prognostic Value Noted
May 22, 2013 / GenomeWeb Daily News